DNA X Q2 FY26 net loss from continuing operations narrows to USD 1.24 million; revenue holds at no revenue

Reuters2026/08/19 20:16

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

DNA X posted a GAAP net loss of USD 1.25 million for Q2, versus a GAAP net loss of USD 7.48 million a year earlier.
GAAP revenue from continuing operations was no revenue, with the AI trading platform closed to the public during the quarter.
G&A expense from continuing operations fell 13.12% to USD 1.28 million, reflecting a post-legacy-business downsizing.
Cash and cash equivalents ended the quarter at USD 900,000; the company raised USD 1.8 million cash from new convertible debt in Q2.
Balance sheet actions included cancelling a USD 3.1 million convertible note for preferred stock at USD 6 per share; a further USD 5 million preferred stock raise followed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608191615PRIMZONEFULLFEED9812980) on August 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

DNA X Q2 FY26 net loss from continuing operations narrows to USD 1.24 million; revenue holds at no revenue

You may also like

Crypto prices